CJEU Confirms 'Pay For Delay' Settlements Can Break EU Law
Ruling Will Help Competition Bodies Tackle 'Harmful Behaviour'
Executive Summary
The UK’s Competition and Markets Authority has welcomed an EU Court of Justice ruling that settling patent disputes can break EU law by restricting competition. The case involved so-called "pay for delay" settlements regarding generic competitors to GlaxoSmithKline's antidepressant Seroxat (paroxetine).